Diagnosing HER2-mutated NSCLC

Opinion
Video

A panel of thoracic oncologists introduce themselves and discuss biomarker testing strategies and the diagnosis of HER2 non–small cell lung cancer (NSCLC).

Related Videos
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Video 15 - "Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment"
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Video 8 - "The Evolving Landscape of Second-Line Therapies in HCC Management"
Video 7 - "Comorbidity Considerations for HCC Treatment"
D. Ross Camidge, MD, PhD
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
D. Ross Camidge, MD, PhD
Related Content
FDA

SNB-101 Receives FDA Fast Track Designation for SCLC

May 10th 2024
Article
Hari B. Keshava, MD

Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection

October 23rd 2023
Podcast
Margie Clapper, PhD, Co-Leader, Cancer Prevention and Control Research Program, Samuel M.V. Hamilton Chair in Cancer Prevention, Fox Chase Cancer Center

Fox Chase Cancer Center Researchers Show Estrogen Metabolites Contribute to Development of Lung Cancer Among People Who Never Smoked

May 2nd 2024
Article
Adnan F. Danish, MD

Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers

August 7th 2023
Podcast
Nicolas Girard, MD, PhD, of Curie-Montsouris Thorax Institute

Frontline Amivantamab Plus Chemo Receives Positive EU CHMP Opinion for EGFR Exon 20 Insertion+ NSCLC

April 26th 2024
Article
Raj Singh, MD, of The Ohio State University Comprehensive Cancer Center––James

Singh Discusses the Shift Toward Stereotactic Radiation Therapy in Lung Cancer

April 23rd 2024
Article